Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines

  • Sabine Vogler*
  • , Nina Zimmermann
  • , Manuel Alexander Haasis
  • , Verena Knoll
  • , Jaime Espin
  • , Aukje K. Mantel-Teeuwisse
  • , Dimitra Panteli
  • , Fatima Suleman
  • , Veronika J. Wirtz
  • , Zaheer Ud Din Babar
  • *Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in Vienna on 25 and 26 April 2024 will offer a forum for the debate on innovating pharmaceutical policymaking to develop and implement futureproof policy options, which are able to address current and future challenges. The Conference invites a broad audience of stakeholders, including researchers, policymakers, payers, patients, industry and health professionals. The conference topics are organised in three strands: Strand 1 on ‘Local challenges, global learnings’ aims to contribute to lively discussions on the implementation of pharmaceutical policies across the globe. Best-practice examples will be presented, supplemented by case studies of less effective policies which can offer rich learnings. Strand 2 on ‘Strengthening the evidence base’ is the place for presentations and discussions on topics such as health technology assessments, managed entry agreements and real-world data. Strand 3 ‘Futureproofing pharmaceutical policies’ is particularly dedicated to explore innovation in policymaking to achieve sustainable access to affordable medicines.

Original languageEnglish
Article number2335492
Number of pages7
JournalJournal of Pharmaceutical Policy and Practice
Volume17
Issue numberS1
DOIs
Publication statusPublished - 24 Apr 2024

Bibliographical note

Publisher Copyright:
© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Fingerprint

Dive into the research topics of 'Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines'. Together they form a unique fingerprint.

Cite this